Idera Pharmaceuticals, Inc.

NASDAQ:IDRA   3:58:47 PM EDT
1.07
+0.03 (+2.88%)
Earnings Announcements

Idera Pharmaceuticals Reports QTRLY Loss Per Share Of $0.14

Published: 04/29/2021 20:38 GMT
Idera Pharmaceuticals, Inc. (IDRA) - Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update.
Idera Pharmaceuticals Inc - Qtrly Loss per Share $0.14.
Idera Pharmaceuticals Inc - in April 2021, Initiated Reduction in Force That Will Impact About 50% Workforce by May 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.